Summary by Futu AI
KEYSTONE PHARMACEUTICALS ANNOUNCED ON 28 MARCH 2024 THAT IT HAS GRANTED A TOTAL OF 11,197,900 RESTRICTED SHARES TO 104 RESTRICTED SHARE SUBSCRIBERS UNDER THE INITIAL PUBLIC OFFERING RESTRICTED SHARE AWARD SCHEME AND EMPLOYEE SHAREHOLDING SCHEME AND HAS GRANTED A TOTAL OF 11,202,900 SHARES TO 107 SHARE PURCHASE OPTIONS. This includes the granting of a total of 3,890,000 restricted stock units and share options to the three directors, and the granting of the remaining units and share options to employees (including senior management) and a service provider. The awarding act is designed to motivate employees and recognize their contributions to the company and does not come with performance indicators. The restricted units and share purchase rights granted will be assigned to the grantor on a phased basis according...Show More